The management is very hopeful of clocking Ebitda margins close to 14-15 per cent in the second half of FY16, says Joshi.

Canadian importers have agreed to quarantine health products made using raw materials from Sri Krishna Pharmaceuticals.

Piramal Enterprises today said it has received approval from the USFDA for its investigational new drug, P11187, that aims to target diabet...

Natco Pharma has received US health regulator's approval to market anti-ulcer drug, Lansoprazole delayed release capsules, in the American ...

India's biggest drug maker Ranbaxy Laboratories today reported a 79 per cent jump in its net profit at Rs 128.7 crore for the first quarter...